Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cancer Drug Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Drug Therapymarket, defines the market attractiveness level of Cancer Drug Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Drug Therapy industry, describes the types of Cancer Drug Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Drug Therapy market and the development prospects and opportunities of Cancer Drug Therapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Drug Therapy market in Chapter 13.
By Player:
Amgen / Allergan
Argos Therapeutics
Genentech (Roche)
Novartis
Aveo Pharmaceuticals
Merck
Prometheus Labs
Exelixis
Bristol-Myers Squibb
Roche
AstraZeneca
Genentech (Bristol-Myers Squibb)
Eisai
Pfizer
Bayer
By Type:
Targeted Therapy
Chemotherapy
Immunotherapy
By End-User:
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Drug Therapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Drug Therapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Drug Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Drug Therapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Drug Therapy Market Analysis and Outlook to 2022
-
7.1 Global Cancer Drug Therapy Consumption (2017-2022)
-
7.2 United States Cancer Drug Therapy Consumption (2017-2022)
-
7.3 Europe Cancer Drug Therapy Consumption (2017-2022)
-
7.4 China Cancer Drug Therapy Consumption (2017-2022)
-
7.5 Japan Cancer Drug Therapy Consumption (2017-2022)
-
7.6 India Cancer Drug Therapy Consumption (2017-2022)
-
7.7 South Korea Cancer Drug Therapy Consumption (2017-2022)
8 Region and Country-wise Cancer Drug Therapy Market Analysis and Outlook to 2028
-
8.1 Global Cancer Drug Therapy Consumption Forecast (2022-2028)
-
8.2 United States Cancer Drug Therapy Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Drug Therapy Consumption Forecast (2022-2028)
-
8.4 China Cancer Drug Therapy Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Drug Therapy Consumption Forecast (2022-2028)
-
8.6 India Cancer Drug Therapy Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Drug Therapy Consumption Forecast (2022-2028)
9 Global Cancer Drug Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Drug Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Drug Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Angiogenesis Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2.2 Global mTOR Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cytokine Immunotherapy (IL-2) Consumption and Growth Rate (2017-2022)
10 Global Cancer Drug Therapy Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Drug Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Drug Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Angiogenesis Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global mTOR Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Cytokine Immunotherapy (IL-2) Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Drug Therapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Drug Therapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Drug Therapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Drug Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Drug Therapy Market Competitive Analysis
-
14.1 Amgen / Allergan
-
14.1.1 Amgen / Allergan Company Details
-
14.1.2 Amgen / Allergan Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Amgen / Allergan Cancer Drug Therapy Product and Service
-
14.2 Argos Therapeutics
-
14.2.1 Argos Therapeutics Company Details
-
14.2.2 Argos Therapeutics Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Argos Therapeutics Cancer Drug Therapy Product and Service
-
14.3 Genentech (Roche)
-
14.3.1 Genentech (Roche) Company Details
-
14.3.2 Genentech (Roche) Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Genentech (Roche) Cancer Drug Therapy Product and Service
-
14.4 Novartis
-
14.4.1 Novartis Company Details
-
14.4.2 Novartis Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis Cancer Drug Therapy Product and Service
-
14.5 Aveo Pharmaceuticals
-
14.5.1 Aveo Pharmaceuticals Company Details
-
14.5.2 Aveo Pharmaceuticals Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Aveo Pharmaceuticals Cancer Drug Therapy Product and Service
-
14.6 Merck
-
14.6.1 Merck Company Details
-
14.6.2 Merck Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck Cancer Drug Therapy Product and Service
-
14.7 Prometheus Labs
-
14.7.1 Prometheus Labs Company Details
-
14.7.2 Prometheus Labs Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Prometheus Labs Cancer Drug Therapy Product and Service
-
14.8 Exelixis
-
14.8.1 Exelixis Company Details
-
14.8.2 Exelixis Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Exelixis Cancer Drug Therapy Product and Service
-
14.9 Bristol-Myers Squibb
-
14.9.1 Bristol-Myers Squibb Company Details
-
14.9.2 Bristol-Myers Squibb Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bristol-Myers Squibb Cancer Drug Therapy Product and Service
-
14.10 Roche
-
14.10.1 Roche Company Details
-
14.10.2 Roche Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Roche Cancer Drug Therapy Product and Service
-
14.11 AstraZeneca
-
14.11.1 AstraZeneca Company Details
-
14.11.2 AstraZeneca Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 AstraZeneca Cancer Drug Therapy Product and Service
-
14.12 Genentech (Bristol-Myers Squibb)
-
14.12.1 Genentech (Bristol-Myers Squibb) Company Details
-
14.12.2 Genentech (Bristol-Myers Squibb) Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Genentech (Bristol-Myers Squibb) Cancer Drug Therapy Product and Service
-
14.13 Eisai
-
14.13.1 Eisai Company Details
-
14.13.2 Eisai Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Eisai Cancer Drug Therapy Product and Service
-
14.14 Pfizer
-
14.14.1 Pfizer Company Details
-
14.14.2 Pfizer Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Pfizer Cancer Drug Therapy Product and Service
-
14.15 Bayer
-
14.15.1 Bayer Company Details
-
14.15.2 Bayer Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Bayer Cancer Drug Therapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Drug Therapy
-
Figure Cancer Drug Therapy Picture
-
Table Global Cancer Drug Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Drug Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Drug Therapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Drug Therapy Consumption by Country (2017-2022)
-
Figure United States Cancer Drug Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Drug Therapy Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Drug Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Drug Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Drug Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Drug Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Drug Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Drug Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Drug Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Drug Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Drug Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Drug Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Drug Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Angiogenesis Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global mTOR Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Cytokine Immunotherapy (IL-2) Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Angiogenesis Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global mTOR Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cytokine Immunotherapy (IL-2) Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Drug Therapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Drug Therapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Amgen / Allergan (Foundation Year, Company Profile and etc.)
-
Table Amgen / Allergan Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen / Allergan Cancer Drug Therapy Product and Service
-
Table Argos Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Argos Therapeutics Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Argos Therapeutics Cancer Drug Therapy Product and Service
-
Table Genentech (Roche) (Foundation Year, Company Profile and etc.)
-
Table Genentech (Roche) Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech (Roche) Cancer Drug Therapy Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Cancer Drug Therapy Product and Service
-
Table Aveo Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Aveo Pharmaceuticals Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aveo Pharmaceuticals Cancer Drug Therapy Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Cancer Drug Therapy Product and Service
-
Table Prometheus Labs (Foundation Year, Company Profile and etc.)
-
Table Prometheus Labs Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prometheus Labs Cancer Drug Therapy Product and Service
-
Table Exelixis (Foundation Year, Company Profile and etc.)
-
Table Exelixis Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Exelixis Cancer Drug Therapy Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Cancer Drug Therapy Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Cancer Drug Therapy Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Cancer Drug Therapy Product and Service
-
Table Genentech (Bristol-Myers Squibb) (Foundation Year, Company Profile and etc.)
-
Table Genentech (Bristol-Myers Squibb) Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech (Bristol-Myers Squibb) Cancer Drug Therapy Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Cancer Drug Therapy Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Cancer Drug Therapy Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Cancer Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Cancer Drug Therapy Product and Service
-
